Supplemental Table 2.
Baseline characteristics of arrhythmogenic right ventricular cardiomyopathy (ARVC) and control off at ≥ 50, ≥ 100 and ≥ 200 ventricular premature complexes (VPC), respectively.
| Parameter | ARV C: Cut-off ≥ 50 VPC | ARV C: Cut-off ≥ 100 VPC | ARVC: Cu | ||||
|---|---|---|---|---|---|---|---|
| ARVC (n = 46) |
Controls (n = 218) |
p-value | ARVC (n = 43) |
Controls (n = 221) |
p-value | ARVC (n = 40) |
|
| Male Sex | 22 (47.8%) |
114 (55.0%) |
0.417 | 20 (46.5%) |
122 (55.2) |
0.319 | 18 (45.0%) |
| Age | 7.22 ± 3.39 |
4.89 ± 3.20 |
0.000 | 7.31 ± 3.36 |
4.91 ± 3.21 |
0.000 | 7.18 ±3.35 |
| Echocardiogram | 45 (97.8%) |
216 (99.0%) |
0.438 | 42 (97.7%) |
219 (99.1%) |
0.415 | 39 (97.5%) |
| 24h-ECG | 46 (100%) |
85 (39.0%) |
0.000 | 43 (100%) |
88 (39.8%) |
0.000 | 40 (100%) |
| (Pre-) Syncope | 35 (83.3%) (n = 42) |
85 (49.7%) (n = 171) |
0.000 | 33 (84.6%) (n = 39) |
87 (50.0%) (n = 174) |
0.000 | 31 (86.1%) (n = 36) |
| (Pre-) Syncope at exertion | 14 (33.3%) |
40 (23.4%) |
0.234 | 13 (33.3%) |
41 (23.6%) |
0.224 | 12 (33.3%) |
| BNP | 2022 ±789 (n = 7) |
1673 ± 1184 (n=33) |
0.462 | 2022 ± 789 (n = 7) |
1673 ± 1184 (n = 33) |
0.462 | 2022 ± 789 (n = 7) |
| Troponin | 1.71 ±3.51 (n = 16) |
0.72 ± 2.32 (n=63) |
0.177 | 1.80 ± 3.61 (n = 15) |
0.72 ± 2.30 (n = 64) |
0.148 | 1.80 ±3.61 (n = 15) |
BNP: brain natriuretic peptide.